Title |
Nanopharmacology in translational hematology and oncology
|
---|---|
Published in |
International Journal of Nanomedicine, July 2014
|
DOI | 10.2147/ijn.s60488 |
Pubmed ID | |
Authors |
Ciprian Tomuleasa, Cornelia Braicu, Alexandra Irimie, Lucian Craciun, Ioana Berindan-Neagoe |
Abstract |
Nanoparticles have displayed considerable promise for safely delivering therapeutic agents with miscellaneous therapeutic properties. Current progress in nanotechnology has put forward, in the last few years, several therapeutic strategies that could be integrated into clinical use by using constructs for molecular diagnosis, disease detection, cytostatic drug delivery, and nanoscale immunotherapy. In the hope of bringing the concept of nanopharmacology toward a viable and feasible clinical reality in a cancer center, the present report attempts to present the grounds for the use of cell-free nanoscale structures for molecular therapy in experimental hematology and oncology. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
France | 1 | 2% |
Unknown | 61 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 16% |
Student > Master | 9 | 15% |
Student > Ph. D. Student | 8 | 13% |
Researcher | 6 | 10% |
Student > Doctoral Student | 3 | 5% |
Other | 11 | 18% |
Unknown | 15 | 24% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 16% |
Biochemistry, Genetics and Molecular Biology | 7 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
Chemistry | 5 | 8% |
Agricultural and Biological Sciences | 4 | 6% |
Other | 13 | 21% |
Unknown | 18 | 29% |